Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Current treatments for common male hair loss have limited effectiveness and can cause side effects.

Minoxidil and finasteride are common but limited treatments for hair loss, with new therapies showing promise.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

New treatments for male hypogonadism are effective and should be personalized.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

Interest in new and personalized treatments for hair loss is growing.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Hormone treatment caused hair loss, finasteride helped regrowth.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The normal human prostate does not significantly affect blood DHT levels.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Analog 23 is a promising compound for prostate cancer treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Estrogen may help improve COVID-19 outcomes, especially in women.